WHO halts malaria drug in COVID-19 trials
Video Credit: Reuters Studio - Duration: 01:05s - Published
WHO halts malaria drug in COVID-19 trials
The World Health Organization said on Saturday that it was discontinuing its trials of the malaria drug hydroxychloroquine and combination HIV drug lopinavir/ritonavir in hospitalized patients with COVID-19 after they failed to reduce mortality.
This report produced by Jillian Kitchener.
